Impact of COVID-19 on Chronic Disease Management
Summary
The COVID-19 pandemic has profoundly disrupted the routine care and long-term oversight of chronic diseases worldwide. Stay-at-home orders and reallocation of healthcare resources led to delayed diagnoses, reduced monitoring of key risk factors and interruption of scheduled interventions. Many health systems adopted remote consultations and expanded digital monitoring, yet gaps in access to diagnostics, medications and allied support services persisted. Patients with cardiovascular disease, diabetes, respiratory disorders and other long-term conditions faced heightened vulnerability not only to infection but also to disease progression when routine measurements, such as blood pressure or glycated haemoglobin, were deferred or cancelled. Socioeconomic inequalities were amplified, with disadvantaged communities experiencing more severe service disruption and poorer recovery of care pathways. Moreover, psychosocial stress, changes in lifestyle behaviours and food insecurity further undermined self-management. At the same time, the crisis has accelerated innovation in telemedicine, home-based monitoring and integrated care models, offering a blueprint for more resilient chronic disease management. Lessons learned from this period emphasise the need for flexible service delivery, prioritisation of high-risk groups and stronger linkage between digital tools and traditional care to safeguard continuity and equity in long-term condition management.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Impact of COVID-19 on Chronic Disease Management publication trend
The graph below shows the total number of articles in impact of covid-19 on chronic disease management across all publications each year (not limited to Nature Index journals).
Technical terms
Cardiometabolic risk factors: Clinical measurements such as blood pressure, cholesterol and glycated haemoglobin that indicate future risk of cardiovascular and metabolic disease.
Glycated haemoglobin (HbA1c): A biomarker reflecting average blood glucose levels over the preceding two to three months, used to assess glycaemic control in diabetes.
Syndemic: The synergistic interaction of two or more health conditions, such as a communicable disease and non-communicable disorders, that exacerbate overall health outcomes.
Non-communicable diseases (NCDs): Chronic conditions not transmitted between individuals, including cardiovascular disease, diabetes, chronic respiratory illness and cancer.
References
- Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study. PLOS Medicine (2024).
- The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health (2022).
- Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study. BMC Public Health (2021).
- COVID-19 and Chronic Disease: The Impact Now and in the Future. Preventing Chronic Disease (2021).
- Accessibility to Non-COVID Health Services in the World During the COVID-19 Pandemic: Review. Frontiers in Public Health (2021).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.